OIS RETINA 2023 SPEAKERS

Ursula-Schmidt-Erfurth-MD

Ursula Schmidt-Erfurth, MD

By Maureen Linnemann | June 7, 2023

Ursula Schmidt-Erfurth is Professor and Chair of the Department of Ophthalmology at the University Eye Hospital, Vienna, Austria, one of the largest academic institutions in…

Read More

Justis Ehlers, MD

By Priscilla Villarreal | June 7, 2023

Justis P. Ehlers, MD serves as the Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research at the Cole Eye Institute of the…

Read More
Omer Trivizki, MD, MBA

Omer Trivizki, MD, MBA

By Maureen Linnemann | June 7, 2023
Read More

Lejla Vajzovic, MD

By Priscilla Villarreal | June 7, 2023

Dr. Vajzovic is a vitreoretinal surgeon and tenured Associate Professor of Ophthalmology at Duke University School of Medicine with expertise in adult and pediatric retinal…

Read More

SriniVas R. Sadda, MD

By Maureen Linnemann | June 7, 2023

SriniVas R. Sadda, MD, is the Director, Artificial Intelligence & Imaging Research, Doheny Eye Institute and Professor of Ophthalmology at the University of California –…

Read More

Lori-Ann Christie, PhD

By Jackie Wengrod | May 24, 2023

Lori-Ann Christie joined Visionary Venture Fund in 2021 as a principal where she identifies investment opportunities, conducts due diligence, and provides strategic guidance to companies…

Read More

Nadia Waheed, MD

By Jackie Wengrod | May 24, 2023

Dr. Nadia Waheed is Associate Professor in Ophthalmology at the Tufts University School of Medicine in Boston and Director of the Boston Image Reading Center.…

Read More
David Sarraf, MD

David Sarraf, MD

By Jackie Wengrod | May 24, 2023

Dr. David Sarraf is Clinical Professor of Ophthalmology at the Stein Eye Institute at UCLA and member of the Retinal Disorders and Ophthalmic Genetics Division.…

Read More

Anupam Dalal, MD

By Jackie Wengrod | May 24, 2023

Dr. Anupam Dalal is a Chief Investment Officer at Acuta Capital Partners LLC. He is responsible for managing healthcare investments, with a focus on biotech.…

Read More
Andrew Moshfeghi, MD, MBA

Andrew A. Moshfeghi, MD, MBA

By Jackie Wengrod | May 24, 2023

Andrew A. Moshfeghi, MD, MBA, earned his medical degree from Tulane University School of Medicine in 1999. Following the completion of his residency in ophthalmology,…

Read More

Adrian Morris

By Jackie Wengrod | May 24, 2023

Adrian is Chief Development Officer at jCyte, a clinical stage biotech company dedicated to preserving and restoring vision in patients with degenerative retinal disorders. Its…

Read More
Peter Kaiser, MD

Peter Kaiser, MD

By Marie Glenn Vasquez | December 14, 2022

Peter K. Kaiser, MD graduated magna cum laude with Highest Honors from Harvard College and Harvard Medical School. He completed an ophthalmology residency at the…

Read More

SUBSCRIBE TO OIS NEWS

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.

We respect your privacy and promise to never send you spam.

Something went wrong. Please check your entries and try again.